25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study
- PMID: 18541825
- PMCID: PMC3719391
- DOI: 10.1001/archinte.168.11.1174
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study
Abstract
Background: Vitamin D deficiency may be involved in the development of atherosclerosis and coronary heart disease in humans.
Methods: We assessed prospectively whether plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with risk of coronary heart disease. A nested case-control study was conducted in 18,225 men in the Health Professionals Follow-up Study; the men were aged 40 to 75 years and were free of diagnosed cardiovascular disease at blood collection. The blood samples were returned between April 1, 1993, and November 30, 1999; 99% were received between April 1, 1993, and November 30, 1995. During 10 years of follow-up, 454 men developed nonfatal myocardial infarction or fatal coronary heart disease. Using risk set sampling, controls (n = 900) were selected in a 2:1 ratio and matched for age, date of blood collection, and smoking status.
Results: After adjustment for matched variables, men deficient in 25(OH)D (<or=15 ng/mL [to convert to nanomoles per liter, multiply by 2.496]) were at increased risk for MI compared with those considered to be sufficient in 25(OH)D (>or=30 ng/mL) (relative risk [RR], 2.42; 95% confidence interval [CI], 1.53-3.84; P < .001 for trend). After additional adjustment for family history of myocardial infarction, body mass index, alcohol consumption, physical activity, history of diabetes mellitus and hypertension, ethnicity, region, marine omega-3 intake, low- and high-density lipoprotein cholesterol levels, and triglyceride levels, this relationship remained significant (RR, 2.09; 95% CI, 1.24-3.54; P = .02 for trend). Even men with intermediate 25(OH)D levels were at elevated risk relative to those with sufficient 25(OH)D levels (22.6-29.9 ng/mL: RR, 1.60 [95% CI, 1.10-2.32]; and 15.0-22.5 ng/mL: RR, 1.43 [95% CI, 0.96-2.13], respectively).
Conclusion: Low levels of 25(OH)D are associated with higher risk of myocardial infarction in a graded manner, even after controlling for factors known to be associated with coronary artery disease.
Comment in
-
A ray of sunshine for the vitamin D-heart hypothesis.Arch Intern Med. 2009 Feb 23;169(4):416-7. doi: 10.1001/archinternmed.2008.607. Arch Intern Med. 2009. PMID: 19237728 No abstract available.
Similar articles
-
Plasma adiponectin levels and risk of myocardial infarction in men.JAMA. 2004 Apr 14;291(14):1730-7. doi: 10.1001/jama.291.14.1730. JAMA. 2004. PMID: 15082700
-
Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years.Atherosclerosis. 2012 Jul;223(1):223-9. doi: 10.1016/j.atherosclerosis.2012.04.014. Epub 2012 May 8. Atherosclerosis. 2012. PMID: 22652526
-
Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study.J Clin Endocrinol Metab. 2013 Jan;98(1):272-80. doi: 10.1210/jc.2012-2368. Epub 2012 Nov 12. J Clin Endocrinol Metab. 2013. PMID: 23150690
-
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.JAMA. 1996 Sep 18;276(11):882-8. JAMA. 1996. PMID: 8782637
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article. Review.
Cited by
-
Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs.Ann Med Surg (Lond). 2024 Aug 14;86(11):6665-6672. doi: 10.1097/MS9.0000000000002458. eCollection 2024 Nov. Ann Med Surg (Lond). 2024. PMID: 39525782 Free PMC article. Review.
-
The Impact of Atorvastatin Treatment on the Distribution of Low-Density Lipoprotein Subfractions and the Level of Vitamin D in Patients After Acute Myocardial Infarction: Preliminary Findings.Int J Mol Sci. 2024 Oct 19;25(20):11264. doi: 10.3390/ijms252011264. Int J Mol Sci. 2024. PMID: 39457047 Free PMC article.
-
Vitamin D and cardiovascular diseases: A narrative review.J Family Med Prim Care. 2024 Apr;13(4):1191-1199. doi: 10.4103/jfmpc.jfmpc_1481_23. Epub 2024 Apr 22. J Family Med Prim Care. 2024. PMID: 38827691 Free PMC article. Review.
-
Prediagnostic plasma proteomics profile for hepatocellular carcinoma.J Natl Cancer Inst. 2024 Aug 1;116(8):1343-1355. doi: 10.1093/jnci/djae079. J Natl Cancer Inst. 2024. PMID: 38688524
-
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.Biomedicines. 2024 Mar 30;12(4):768. doi: 10.3390/biomedicines12040768. Biomedicines. 2024. PMID: 38672124 Free PMC article. Review.
References
-
- Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005;94:483–492. - PubMed
-
- Lund B, Badskjaer J, Lund B, Soerensen OH. Vitamin D and ischaemic heart disease. Horm Metab Res. 1978;10:553–556. - PubMed
-
- Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19:559–563. - PubMed
-
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
